Pfizer Wins Exclusion Of Professor's Report In Zoloft MDL

Law360, New York (June 30, 2014, 2:13 PM EDT) -- A Pennsylvania federal judge has granted Pfizer Inc.’s motion to exclude from multidistrict litigation the testimony of a Canadian professor linking birth defects to pregnant women’s use of the antidepressant Zoloft, saying her methods are not scientifically sound.

The plaintiffs claim that sertraline, which Pfizer markets as Zoloft, causes potentially fatal birth defects and that Pfizer should have warned the medical community and consumers. Anick Berard, a perinatal pharmacoepidemiologist, had testified for the plaintiffs, but U.S. District Judge Cynthia M. Rufe on Friday said Berard’s conclusions were only possible due to her departure from established epidemiological methods.

According to the judge,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!